Isabel R Preeshagul (Isabel Preeshagul)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Epidermal Growth Factor Receptor

Chronic Myeloid Leukemia

Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Noura J Choudhury, W Victoria Lai, Alex Makhnin, Glenn Heller, Juliana Eng, Bob T Li, Isabel R Preeshagul, Fernando C Santini, Michael D Offin, Kenneth Ng, Paul K Paik, Christina Larsen, Michelle S Ginsberg, Yvonne Lau, Xinyuan Zhang, Marina K Baine, Natasha Rekhtman, Charles M Rudin
A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Noura J Choudhury, W Victoria Lai, Alex Makhnin, Glenn Heller, Juliana Eng, Bob T Li, Isabel R Preeshagul, Fernando C Santini, Michael D Offin, Kenneth Ng, Paul K Paik, Christina Larsen, Michelle S Ginsberg, Yvonne Lau, Xinyuan Zhang, Marina K Baine, Natasha Rekhtman, Charles M Rudin
A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Noura J Choudhury, W Victoria Lai, Alex Makhnin, Glenn Heller, Juliana Eng, Bob T Li, Isabel R Preeshagul, Fernando C Santini, Michael D Offin, Kenneth Ng, Paul K Paik, Christina Larsen, Michelle S Ginsberg, Yvonne Lau, Xinyuan Zhang, Marina K Baine, Natasha Rekhtman, Charles M Rudin
A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Rohit Thummalapalli, Ezra Bernstein, Benjamin O Herzberg, Bob T Li, Afsheen Iqbal, Isabel R Preeshagul, Fernando C Santini, Juliana Eng, Marc Ladanyi, Soo-Ryum Yang, Ronglai Shen, Piro Lito, Gregory J Riely, Joshua K Sabari, Kathryn C Arbour
Clinical and Genomic Features of Response and Toxicity to Sotorasib in a Real-World Cohort of Patients With Advanced KRAS G12C -Mutant Non-Small Cell Lung Cancer. JCO precision oncology 7 (2023)
Humera Khurshid, Nofisat Ismaila, Jessica Bian, Raetasha Dabney, Millie Das, Peter Michael Ellis, Jill Feldman, Christine L Hann, Swati Kulkarni, Janessa Laskin, Rami Manochakian, Deebya Raj Mishra, Isabel R Preeshagul, Pavan S Reddy, Ashish Saxena, Frank Weinberg, Gregory P Kalemkerian
Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Arielle Elkrief, Alex Makhnin, Khadeja A Moses, Linda S Ahn, Isabel R Preeshagul, Afsheen N Iqbal, Sara A Hayes, Andrew J Plodkowski, Paul K Paik, Marc Ladanyi, Mark G Kris, Gregory J Riely, Franziska Michor, Helena Alexandra Yu
Brief report: Combination of Osimertinib and Dacomitinib to mitigate primary and acquired resistance in EGFR-mutant lung adenocarcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Arielle Elkrief, Alex Makhnin, Khadeja A Moses, Linda S Ahn, Isabel R Preeshagul, Afsheen N Iqbal, Sara A Hayes, Andrew J Plodkowski, Paul K Paik, Marc Ladanyi, Mark G Kris, Gregory J Riely, Franziska Michor, Helena Alexandra Yu
Brief report: Combination of Osimertinib and Dacomitinib to mitigate primary and acquired resistance in EGFR-mutant lung adenocarcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Noura J Choudhury, Alex Makhnin, Yosef Y Tobi, Robert M Daly, Isabel R Preeshagul, Afsheen N Iqbal, Linda S Ahn, Sara A Hayes, Glenn Heller, Mark G Kris, Gregory J Riely, Helena A Yu
Pilot Study of Dacomitinib for Patients With Metastatic EGFR-Mutant Lung Cancers With Disease Progression After Initial Treatment With Osimertinib. JCO precision oncology 5 (2021)
Jia Luo, Hira Rizvi, Jacklynn V Egger, Isabel R Preeshagul, Jedd D Wolchok, Matthew D Hellmann
Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers. Cancer discovery 10 (8) (2020)